Evidence map›Paper›PMID 38393324›Full record

ArticleJournal of clinical microbiology2024

This is giving me a complex: a practical attempt to streamline nontuberculous mycobacteria nomenclature for clinical purposes.

Nancy L Wengenack, Barbara A Brown-Elliott, Nicole M Parrish, Max Salfinger, Christine Y Turenne, Richard J Wallace, Adrian M Zelazny

Abstract readLetter
In one paragraph

Article in Journal of clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Comparative Analysis of Evolutionary Distances Using the GenusInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Biochip-Based Identification of Mycobacterial Species in Russia.International journal of molecular sciences · 2024
    Article
  6. Article
  7. Growing from common ground: nontuberculous mycobacteria and bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nancy L WengenackDivision of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0003-2853-8219
Barbara A Brown-ElliottMycobacteria/Nocardia Research Laboratory, University of Texas at Tyler Health Science Center, School of Medicine Tyler, Tyler, Texas, USA.ORCID 0000-0002-3091-1169
Nicole M ParrishDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-4263-228X
Max SalfingerUniversity of South Florida College of Public Health and Morsani College of Medicine, Tampa, Florida, USA.ORCID 0000-0003-4061-6486
Christine Y TurenneDepartment of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0003-1366-3682
Richard J WallaceMycobacteria/Nocardia Research Laboratory, University of Texas at Tyler Health Science Center, School of Medicine Tyler, Tyler, Texas, USA.
Adrian M ZelaznyDepartment of Laboratory Medicine, Microbiology Service, Clinical Center, NIH, Bethesda, Maryland, USA.ORCID 0000-0003-2847-7428

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cystic FibrosisMycobacterium Infections, NontuberculousHumansNontuberculous MycobacteriaMycobacteriumnomenclaturenontuberculous mycobacteria

Identifiers

PMID38393324
PMCPMC10935656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.